NASDAQ · Medical - Devices

ADGM (ADGM) Stock

$0.38 +1.60% NASDAQ: ADGM Healthcare

Valuation

MetricValue
Price$0.38
Market Cap$8.45M
P/E Ratio-0.56
P/B Ratio1.07
P/S Ratio0.00
EPS (TTM)$-1.51
52-Week High$2.58
52-Week Low$0.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-208.33%
ROA-58.14%
ROCE-183.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity4.21
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-21.0M$-24.0M$-28.0M$-62.0M$-22.0M
Net Profit$-20.0M$-24.0M$-38.0M$-54.0M$-25.0M
EPS$-0.34$0.06$-4.86$-3.54$-1.51
Op Margin-7646.3%-12652.4%-9314.0%-23226.8%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$21.0M$9.0M$7.0M$48.0M$43.0M
Total Liabilities$94.0M$105.0M$139.0M$29.0M$31.0M
Cash$19.0M$6.0M$1.0M$21.0M$17.0M
Borrowings$0$10.0M$38.0M$16.0M$22.0M

Latest News

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System Business Wire · Aug 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-22.0M$-26.0M$-29.0M$-19.0M
Investing Cash Flow$-3.0M$-1.0M$-1.0M$-3.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-20.0M$5.0M$-4.0M$21.0M$-3.0M
Free Cash Flow$-21.0M$-23.0M$-26.0M$-31.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-121.42%
Quick Ratio1.66
Interest Coverage-7.33
Return 1Y-60.70%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
COCH $0.67 +1.71% -0.74 $14.02M 0.00%
CODX $2.04 -2.86% -0.11 $2.28M 0.00%
CTXR $0.57 -9.81% -0.68 $6.37M 0.00%

About ADGM

ADGM is led by CEO Todd Usen, employs 80 people, headquartered in US, publicly traded since 2024.

ADGM stock trades at $0.38 with a market capitalization of $8.45M. The stock is valued at a price-to-earnings (P/E) ratio of -0.56, price-to-book of 1.07, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.38 and $2.58, and currently trades 85.3% below its 52-week high.

On profitability, ADGM generates a return on equity (ROE) of -208.33%, return on capital employed of -183.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides